In our latest episode, Brad Niles, CEO of ARIZ Precision Medicine, shares his journey from unusual early ventures (like breeding mice and wedding pigeons!) to leading a biotech company working on cutting-edge lung cancer therapies.
Brad opens up about what inspired him to start ARIZ, how personal experiences with cancer shaped his mission, and how his team is developing siRNA-based treatments that target specific genetic drivers like the Prdm2 gene—offering the potential for more precise, less toxic cancer care.
We also talk about:
It’s an honest and inspiring look at what drives founders in healthtech—and why staying optimistic and resilient matters more than ever.
🎙️ Tune in now!
https://podcasts.apple.com/us/podcast/why-optimism-and-resilience-are-non-negotiable-in/id1716394190?i=1000713652471